Medical device company Globus Medical (NYSE:GMED) in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On the other hand, the company’s full-year revenue guidance of $2.85 ...

Globus Medical said the purchase would increase its portfolio of musculoskeletal technologies, therefore enhancing its position in neuromodulation and chronic pain management. Nevro, with its ...

AUDUBON, PA & REDWOOD CITY, CA — Globus Medical (NYSE: GMED) has announced a definitive agreement to acquire all shares of ...

Have you been paying attention to shares of Globus Medical (GMED)? Shares have been on the move with the stock up 7.3% over the past month. The stock hit a new 52-week high of $70.84 in the ...

Globus Medical’s initiative of offering robotics-driven surgical solutions is driving its long-term revenue growth. The company’s orthopedic trauma solutions enjoy strong demand in the ...

Globus Medical, Inc. GMED is gaining from strength in the Enabling Technologies arm. The company exited the third quarter with better-than-expected earnings. The robust performance by ExcelsiusGPS ...